For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

21st May 12

Pharmaxis Submits US New Drug Application for Bronchitol

Pharmaceutical company Pharmaxis (ASX: PXS) is pleased to announce it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) seeking approval for Bronchitol® for the treatment of patients with cystic fibrosis in the United States.  The FDA has previously granted Bronchitol Orphan Drug designation for the treatment of patients with cystic fibrosis.


Read full media release - pdf